Free Trial

NextCure (NXTC) Short Interest Ratio & Short Volume

$1.62
-0.05 (-3.28%)
(As of 12:39 PM ET)

NextCure Short Interest Data

Current Short Interest
112,400 shares
Previous Short Interest
113,200 shares
Change Vs. Previous Month
-0.71%
Dollar Volume Sold Short
$136,004.00
Short Interest Ratio
0.4 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
27,970,000 shares
Float Size
21,150,000 shares
Short Percent of Float
0.53%
Today's Trading Volume
29,848 shares
Average Trading Volume
212,204 shares
Today's Volume Vs. Average
14%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling NextCure ?

Sign up to receive the latest short interest report for NextCure and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NXTC Short Interest Over Time

NXTC Days to Cover Over Time

NXTC Percentage of Float Shorted Over Time

NextCure Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024112,400 shares $136,004.00 -0.7%0.5%0.4 $1.21
4/15/2024113,200 shares $189,044.00 -88.6%0.5%0.4 $1.67
3/31/2024993,800 shares $2.22 million +18.4%4.7%3.8 $2.23
3/15/2024839,700 shares $1.22 million +579.9%4.0%3.7 $1.45
2/29/2024123,500 shares $213,655.00 +4.7%0.6%0.7 $1.73
2/15/2024118,000 shares $166,380.00 +8.4%0.6%1.1 $1.41
1/31/2024108,900 shares $132,858.00 -11.8%0.6%1.2 $1.22
1/15/2024123,400 shares $143,144.00 -42.8%0.6%1.3 $1.16
12/31/2023215,800 shares $246,012.00 -6.2%1.1%2.2 $1.14
12/15/2023230,000 shares $255,300.00 +17.3%1.2%2.3 $1.11
11/30/2023196,100 shares $231,398.00 -0.6%1.0%3.2 $1.18
11/15/2023197,200 shares $246,500.00 +0.1%1.0%3.7 $1.25
10/31/2023197,000 shares $202,910.00 -1.5%1.0%3.7 $1.03
10/15/2023199,900 shares $249,875.00 -13.2%1.0%4.7 $1.25
9/30/2023230,300 shares $297,087.00 +11.9%1.2%6.4 $1.29
9/15/2023205,900 shares $284,142.00 -2.5%1.1%4.8 $1.38
8/31/2023211,100 shares $308,206.00 +0.3%1.1%5.2 $1.46
8/15/2023210,500 shares $357,850.00 -1.5%1.1%4.8 $1.70
7/31/2023213,800 shares $367,736.00 -3.5%1.1%4.2 $1.72
7/15/2023221,600 shares $390,016.00 -17.9%1.1%4.1 $1.76
6/30/2023269,800 shares $485,640.00 +7.2%1.4%4.7 $1.80
6/15/2023251,700 shares $420,339.00 +6.6%1.3%4.7 $1.67
5/31/2023236,100 shares $406,092.00 -12.2%1.2%3.9 $1.72
5/15/2023268,900 shares $457,856.03 +4.3%1.4%3.8 $1.70
4/30/2023257,800 shares $389,278.00 -4.1%1.3%3.4 $1.51
4/15/2023268,700 shares $403,050.00 -15.4%1.4%3.2 $1.50
3/31/2023317,700 shares $470,196.00 -3.8%1.6%3.5 $1.48
3/15/2023330,300 shares $518,571.00 -6.9%1.7%2.1 $1.57
2/28/2023354,900 shares $550,095.00 +14.7%1.8%2.1 $1.55
2/15/2023309,500 shares $485,915.00 -7.3%1.6%1.7 $1.57
1/31/2023333,900 shares $557,613.00 -0.2%1.9%1.7 $1.67
1/15/2023334,700 shares $538,867.00 -9.5%1.9%1.7 $1.61
12/30/2022369,800 shares $521,418.00 -12.5%2.1%1.9 $1.41
12/15/2022422,600 shares $549,380.00 +3.4%2.4%2.5 $1.30
11/30/2022408,600 shares $576,126.00 -4.3%2.3%3.5 $1.41
11/15/2022426,800 shares $708,488.00 -10.2%2.4%4 $1.66
10/31/2022475,300 shares $1.19 million -11.6%2.7%4.1 $2.50
10/15/2022537,400 shares $1.45 million -8.6%3.3%5.4 $2.70
9/30/2022587,800 shares $1.62 million -3.2%3.6%5.5 $2.75
9/15/2022607,100 shares $2.31 million -21.6%3.7%4.8 $3.81
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
8/31/2022774,000 shares $3.17 million -2.9%4.7%5.2 $4.10
8/15/2022797,000 shares $4.14 million +9.9%4.8%4.5 $5.19
7/31/2022725,100 shares $3.12 million -9.4%4.4%4.1 $4.30
7/15/2022800,000 shares $3.66 million -4.9%4.9%4.6 $4.57
6/30/2022841,200 shares $3.95 million +13.1%5.1%5 $4.70
6/15/2022743,900 shares $3.37 million +21.4%4.5%4.5 $4.53
5/31/2022612,700 shares $2.39 million -4.0%3.7%4.3 $3.90
5/15/2022638,500 shares $2.26 million +1.5%3.9%5.4 $3.54
4/30/2022629,300 shares $2.62 million +0.4%3.8%5.7 $4.16
4/15/2022626,800 shares $3.14 million +2.9%3.8%4.9 $5.01
3/31/2022608,900 shares $2.96 million -5.8%3.7%4.5 $4.86
3/15/2022646,200 shares $3.15 million +2.1%N/A4.4 $4.88
2/28/2022633,000 shares $3.10 million -7.6%3.8%3.8 $4.90
2/15/2022685,100 shares $3.59 million -10.1%4.1%3.7 $5.24
1/31/2022761,900 shares $4.24 million -1.0%4.7%3.2 $5.57
1/15/2022769,700 shares $4.37 million +0.7%4.8%3 $5.68
12/31/2021764,600 shares $4.59 million +11.0%4.8%2.9 $6.00
12/15/2021688,900 shares $4.02 million +3.6%4.3%2.3 $5.83
11/30/2021664,800 shares $4.16 million +16.4%4.1%2.3 $6.25
11/15/2021571,000 shares $3.53 million -6.3%3.6%2.1 $6.18
10/29/2021609,100 shares $5.01 million -8.4%3.9%2.3 $8.22
10/15/2021665,200 shares $5.81 million -15.2%4.3%2.7 $8.73
9/30/2021784,700 shares $5.29 million -4.9%5.1%3.4 $6.74
9/15/2021825,300 shares $6.01 million +4.3%5.3%3.3 $7.28
8/31/2021791,300 shares $6.03 million -15.4%5.1%3.1 $7.62
8/13/2021934,800 shares $6.74 million +0.7%6.0%3.3 $7.21
7/30/2021928,000 shares $6.43 million -9.9%6.0%3.4 $6.93
7/15/20211,030,000 shares $7.42 million +49.8%5.7%3.7 $7.20
6/30/2021687,800 shares $5.52 million -37.5%3.8%2.4 $8.03
6/15/20211,100,000 shares $8.95 million +0.9%6.0%4.6 $8.14
5/28/20211,090,000 shares $8.56 million +5.8%6.0%4.9 $7.85
5/14/20211,030,000 shares $8.25 million -1.0%5.7%4.8 $8.01
4/30/20211,040,000 shares $9.45 million -29.3%5.7%4.6 $9.09
4/15/20211,470,000 shares $13.88 million +1.4%8.1%6.9 $9.44
3/31/20211,450,000 shares $14.22 million -5.2%8.0%6.7 $9.81
3/15/20211,530,000 shares $19.39 million -3.2%8.4%5.5 $12.67
2/26/20211,580,000 shares $18.26 million -18.6%8.7%4.6 $11.56
2/12/20211,940,000 shares $26.93 million +5.4%10.7%5.3 $13.88
1/29/20211,840,000 shares $22.41 million +155.3%10.1%4.8 $12.18
1/15/2021720,800 shares $9.42 million -22.1%4.2%1.8 $13.07
12/31/2020925,100 shares $10.27 million -17.4%5.3%2.4 $11.10
12/15/20201,120,000 shares $13.78 million -32.1%6.5%2.6 $12.30
11/30/20201,650,000 shares $17.13 million +50.0%9.6%4.4 $10.38
11/15/20201,100,000 shares $11.61 million -42.1%6.4%2.9 $10.55
10/30/20201,900,000 shares $19.78 million +6.7%11.1%4.7 $10.41
10/15/20201,780,000 shares $20.74 million -9.6%11.0%3.3 $11.65
9/30/20201,970,000 shares $17.34 million -1.0%N/A2.3 $8.80
9/15/20201,990,000 shares $18.23 million +1.0%12.2%2.3 $9.16
8/31/20201,970,000 shares $17.71 million +8.8%12.1%2.3 $8.99
8/14/20201,810,000 shares $16.51 million -19.2%11.2%2.1 $9.12
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
7/31/20202,240,000 shares $19.98 million +8.7%13.8%2.8 $8.92
7/15/20202,060,000 shares $18.70 million -2.8%12.7%3.1 $9.08
6/30/20202,120,000 shares $47.04 million +21.8%13.1%5.9 $22.19
6/15/20201,740,000 shares $42.49 million +41.5%10.7%5.8 $24.42
5/29/20201,230,000 shares $38.39 million +2.5%7.6%4.5 $31.21
5/15/20201,200,000 shares $42.58 million -4.8%7.4%5.2 $35.48
4/30/20201,260,000 shares $46.24 million +7.7%7.9%5.6 $36.70
4/15/20201,170,000 shares $40.81 million +0.9%7.3%5 $34.88
3/31/20201,160,000 shares $42.35 million -10.5%7.2%5 $36.51
3/13/20201,296,200 shares $52.11 million +11.7%8.1%5.8 $40.20
2/28/20201,160,000 shares $37.49 million +3.6%7.3%4.2 $32.32
2/14/20201,120,000 shares $46.12 million -8.2%7.0%3.3 $41.18
1/31/20201,220,000 shares $54.31 million +6.1%7.6%2.7 $44.52
1/15/20201,150,000 shares $53.43 million +10.6%6.4%2 $46.46
12/31/20191,040,000 shares $46.29 million +120.1%9.2%1.8 $44.51

NXTC Short Interest - Frequently Asked Questions

What is NextCure's current short interest?

Short interest is the volume of NextCure shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 112,400 shares of NXTC short. 0.53% of NextCure's shares are currently sold short. Learn More on NextCure's current short interest.

What is a good short interest percentage for NextCure?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of NextCure's floating shares are currently sold short.

Is NextCure's short interest increasing or decreasing?

NextCure saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 112,400 shares, a drop of 0.7% from the previous total of 113,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NextCure's float size?

NextCure currently has issued a total of 27,970,000 shares. Some of NextCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NextCure currently has a public float of 21,150,000 shares.

How does NextCure's short interest compare to its competitors?

0.53% of NextCure's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NextCure: Xilio Therapeutics, Inc. (5.24%), Clene Inc. (0.53%), Immuneering Co. (15.37%), Aadi Bioscience, Inc. (6.50%), Gain Therapeutics, Inc. (1.02%), Ocuphire Pharma, Inc. (4.71%), Acurx Pharmaceuticals, Inc. (4.67%), BioLineRx Ltd. (0.51%), Daré Bioscience, Inc. (0.29%), HCW Biologics Inc. (0.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short NextCure stock?

Short selling NXTC is an investing strategy that aims to generate trading profit from NextCure as its price is falling. NXTC shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NextCure?

A short squeeze for NextCure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NXTC, which in turn drives the price of the stock up even further.

How often is NextCure's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXTC, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:NXTC) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners